Multidisciplinary Bladder Cancer Care Advisory Committee

Bradley C. Carthon, MD, PhD, is interim director of the division of medical oncology and an associate professor in Emory University School of Medicine's department of hematology and medical oncology in Atlanta, Georgia. Dr. Carthon also serves as section chief of hematology and oncology at Emory University Hospital Midtown. He works with the genitourinary oncology team at Winship Cancer Institute in Druid Hills, Georgia to discover novel therapeutic targets and carry out clinical trials that utilize novel treatment combinations for patients with prostate, bladder, and renal, and other genitourinary malignancies. Dr. Carthon is a member of the Discovery and Developmental Therapeutics research program at Winship Cancer Institute. He is also a member of the Annual Meeting Education Committee for American Society of Clinical Oncology. Dr. Carthon has served as an ASCO University Faculty member and as a member of the ASCO PSA Screening Task Force. He is currently a member of the ASCO Annual Meeting Education Committee for Prostate Cancer and is a member of the NRG Cooperative Group Early Phase Clinical Trials Safety Committee.

Dr. Carthon earned his BS at Hampton University in Hampton, Virginia and went on to receive his doctoral degrees from Harvard Medical School and Harvard University. He completed his residency in internal medicine at Massachusetts General Hospital in Boston.

Stephanie Chisolm, PhD, MEd, is the director of education and research at Bladder Cancer Advocacy Network in Bethesda, Maryland. She actively supports the BCAN mission and works to help raise bladder cancer awareness in the general public with federal and state legislators. 

Dr. Chisolm received her master's degree in education at Rhode Island College in Providence, Rhode Island and completed her PhD in health education and health promotion at the University of Alabama at Birmingham.

Nancy B. Davis, MD, is the vice president for Cancer Care Network and Strategy at Vanderbilt University Medical Center in Nashville, Tennessee.

Dr. Davis received her medical degree at McGovern Medical School at UTHealth in Houston, Texas.

Linda Hayward is a patient financial advocate at the University of Maryland Kaufman Cancer Center at Upper Chesapeake Health. With over a decade in the medical field, including 4 years focused on oncology, she believes that every patient deserves affordable treatment and is dedicated to lightening their financial load. In her role as a patient financial advocate, Hayward guides patients through the process of applying for assistance programs to ensure their treatment is within reach. Last year alone, her efforts translated into a savings of over $1.8 million for patients.

Hayward leads the Uncompensated Care Team, actively participates in tumor boards, and is a member of ACCC. She also volunteers for programs that raise funds to support Cancer LifeNet services at Upper Chesapeake.

Jennifer Hines, MPH is a Patient Financial Advocate at St. Luke’s Cancer Institute in Nampa, ID. In this role, Ms. Hines works closely with patients to uncover their concerns and needs, that may impact their ability to receive treatment and care. Ms. Hines has created surveys and questionnaire tools, statewide landscape and needs-based assessment with the Idaho Department of Health and Welfare in collaboration with the Center for the Study of Aging on Alzheimer’s Disease and Related Dementias, a Covid 19 Emergency Food Relieve for Native Americans in Duck Valley and Migrant Workers with the Idaho Food Bank, promote and created a Sex Culture and Education Program at Boise State University, and worked with students at Endeavor Elementary School in a St. Luke’s Coordinated Approach to Child Health program that used evidence-based coordinated curriculum to promote physical activity, healthy food choices and mindfulness to 520 students aged K-5. Ms. Hines has had research published that was conducted in conjunction with the Idaho department of Agriculture on the spread of Invasive Species of New Zealand Mud Snails in Idaho. 

Ms. Hines holds undergraduate degrees in biology, psychology, and health sciences, and a master’s degree in public health. 

Dr. Heather Honoré Goltz is a licensed master social worker and doctoral-level health educator with over a decade of experience developing and implementing clinical interventions to improve quality of life and health outcomes of patients and caregivers impacted by complex medical and behavioral health conditions.

Dr. Goltz has co-authored almost 30 peer-reviewed articles, primarily focusing on aspects of genitourinary cancer survivorship and sexual health. She has also co-authored or collaborated on several research studies funded by the American Cancer Society, NIH, DOD, and VA.

Dr. Goltz earned a Ph.D. in health education from Texas A&M University prior to completing post-doctoral fellowships at the Michael E. DeBakey VAMC and Baylor College of Medicine. She earned a B.S. in Biology (Scientific Inquiry concentration) from the Louisiana Scholars’ College at Northwestern State University and a M.S.W. (Mental Health concentration) and M.Ed. (Curriculum & Instruction-Teaching) from the University of Houston

Ali Raza Khaki, MD, is a board-certified medical oncologist and a clinical assistant professor at Stanford University School of Medicine in Stanford, California. Dr. Khaki treats patients with genitourinary cancer including kidney, bladder, prostate, and testicular cancer. He is also an editor for HemOnc.org and theMednet, a physician-only online community where members share clinical questions and answers. Dr. Khaki's research interests include using real-world data to investigate effectiveness of novel therapies in patients not well represented in clinical trials with particular interest in bladder cancer. He further studies health care utilization and cost near the end-of-life for patients with advanced cancer.

Dr. Khaki earned his BA in chemistry at Carleton College and his MD at University of California San Diego School of Medicine. He completed his residency in internal medicine at University of California San Francisco and his fellowship in hematology/oncology at the University of Washington/Fred Hutchinson Cancer Research Center in Seattle, Washington.

Chelsea Osterman, MD, is a genitourinary medical oncologist at Mission Health in Ashville, North Carolina. She has expertise in the management of genitourinary malignancies, including bladder, prostate, and kidney cancers, as well as geriatric oncology. Her research focuses on optimizing patient outcomes throughout the cancer care continuum.

Dr. Osterman earned her medical degree at the University of Connecticut Health Centers in Farmington, Connecticut. She completed her residency in internal medicine at the University of Pennsylvania in Philadelphia and completed her fellowship at University of North Carolina at Chapel Hill.

Marc Smaldone, MD, MSHP, FACS is a urologic oncologist specializing in the surgical management of tumors of the kidney, bladder, prostate, adrenal, testis and other genitourinary and an associate professor in the department of surgical oncology at Fox Chase Cancer Center in Philadelphia, Pennsylvania. He is a panel member of NCCN, Prostate Cancer Early Detection. His research interests focus on quality improvement, performance measurement, and improving care coordination at the time of regionalization for complex oncologic care. 

Dr. Smaldone earned his master's of health policy research at the University of Pennsylvania and completed his medical training at the State University of New York at Stony Brook. He earned his residency in urologic surgery at the University of Pittsburgh in Pennsylvania and completed his fellowship in urologic oncology at Fox Chase Cancer Center in Philadelphia.

Susan Taylor, RN, BSN, is a staff nurse in the medical telemetry and intermediate care units at Virginia Mason Medical Center in Seattle, Washington.

Ms. Taylor earned her BS in nursing from Grand Canyon University in Phoenix, Arizona.

Manish A. Vira, MD, Chief of Urologic Oncology at the Northwell Cancer Institute in New Hyde Park, NY. Dr. Vira leads the urologic oncology program in the Smith Institute for Urology. He is an associate professor of urology at the Zucker School of Medicine at Hofstra/Northwell. He specializes in both open and robotic approaches to complex urologic oncology patients. He is the principal investigator of multiple industry sponsored, NCI cooperative group and investigator initiated clinical trials in GU oncology.

Dr. Vira earned his bachelor’s degree in Biochemistry from Rice University. He earned his medical degree from Weill Medical College of Cornell University. He completed his internship in general surgery at NewYork-Presbyterian Hospital. He completed his residency in urology at the University of Pennsylvania. He then completed his fellowship in urologic oncology at the National Cancer Institute, National Institutes of Health.

Samuel L. Washington III, MD, MAS, is an Assistant Professor of Urology in the Departments of Urology and Epidemiology & Biostatistics at the University of California, San Francisco, in San Francisco, CA. Dr. Washington’s primary research focuses on racial disparities in patients with genitourinary malignancies, with specific interests in understanding racial/ethnic disparities in diagnosis, management, and treatment and examining and how these differences in treatment strategies based on race and socioeconomic factors impact survival outcomes for patients with genitourinary cancers.

Dr. Washington’s research interests have led to positions as the Helen Diller Family Comprehensive Cancer Center Prostate Cancer Program Community Outreach and Engagement Liaison, a member of the NCCN Guidelines for Prostate Cancer Early Detection Panel, as well as serving on national committees focused on improving health equity including the Association of Community Cancer Centers Bladder Cancer Advisory Committee and Oncology Clinical Pathways Development Teams for Bladder Cancer, Kidney Cancers, Prostate Cancer for the Veterans Health Administration. 

Dr. Washington completed his undergraduate education at University of California, Davis with a Bachelor of Science degree in Genetics, and a minor in Latin. He completed his medical school training at University of California, San Francisco and was selected by the Department of Urology to complete his urology residency. He stayed on at UCSF to complete his urologic oncology fellowship and a Master of Science degree in Clinical Research.